Background Image
Table of Contents Table of Contents
Previous Page  5 / 48 Next Page
Information
Show Menu
Previous Page 5 / 48 Next Page
Page Background

VOLUME 12 NUMBER 1 • JULY 2015

3

SA JOURNAL OF DIABETES & VASCULAR DISEASE

From the Editor’s Desk

From the Editor’s Desk

T

here is probably no more important topic for discussion than

the effect of lifestyle and diet on our health. The impact of

lifestyle is hugely underestimated by the general public and

is, in my view, by far the biggest contributor to non-communicable

disease today. ‘You are what you eat’ is an old statement that still

holds true.

We, the human race, have lost the plot when it comes to diet,

and our over-consumption of high-calorie and nutritionally poor-

quality food is endangering our health. The food industry, driven

by profit not health, and supported by the advertising industry, has

largely contributed to this problem.

This is very topical currently, and has recently been revived by

Prof Tim Noakes. It was with excitement that I read the review

by the legendary Prof Lionel Opie (page 5) on the topic of diet

and cardiovascular disease. This is a must read for every healthcare

professional who is questioned daily about the Banting and Noakes

diets. The review gives a balanced and scientific opinion on the

different diets and the best options.

Of concern to me is the large number of people who follow

their own version of these diets, unsupervised, with potentially

hazardous consequences. Strong evidence supports the

association between low-density lipoprotein cholesterol (LDL-C)

and cardiovascular disease, and if a diet increases LDL-C levels, it

will very likely increase the risk of cardiovascular disease.

Prospective studies comparing these diets in a large number of

people are urgently needed, to look at surrogate cardiovascular

markers as well as cardiovascular endpoints. Such studies would be

challenging because of people’s inability to stick to a specific diet.

Pop and co-workers (page 8) discuss non-conventional

cardiovascular risk factors that could be used to estimate

cardiovascular risk in women. They highlight many options and

discuss the validity of these risk factors.

A novel approach to peripheral neuropathy is discussed in a very

interesting article by Seewoodhary and others (page 12), using

stem cell transplants. This appears promising, but is unlikely to be

a therapeutic option for diabetic neuropathy in the near future,

and will probably be a very costly option. There are currently not

enough human data to support this mode of therapy.

In a study called the Dyslipidaemia International Study

(DYSIS), Raal and colleagues (page 21) assessed cholesterol

therapy in South African patients in private practice. In total,

1 029 patients were included in the study, and it was shown that

more than 50% of patients did not reach their LDL-C targets

and over 70% were at high cardiovascular risk. Many patients in

South Africa experience persistent dyslipidaemia despite statin

treatment, and further measures are needed to reduce the burden

of cardiovascular disease in our population.

In another observational study assessing lipid control on home

soil, Rapeport and co-workers (page 30) also reported sub-optimal

lipid control in 2 996 patients (52%) from the private and public

sectors. They reported important gender and ethnic differences

and reinforced control of risk factors.

Controlling lipid levels in high-risk patients is a fairly easy

intervention and many potent statins are available at a fair price.

However, drug side effects are sometimes a stumbling block to

achieving our goals. We need to improve on the numbers of

patients reaching target levels in order to lower cardiovascular risk

in our patients, especially in the diabetic subgroup, where glucose

targets are much more difficult to achieve. Target control of glucose

levels is much lower than 50% in diabetic patients, but we know

that lipid control gives much better cardiovascular protection and

therefore this should be a priority, as it is achievable.

Correspondence to: Dr Landi Lombard

Netcare Kuilsriver Hospital, Cape Town

Tel: +27 (0)21 900-6350

e-mail:

lclombard@mweb.co.za

S Afr J Diabetes Vasc Dis

2015;

12

: 3

Image courtesy of Stuart Miles at FreeDigitalPhotos.net